Article
Screening of the transcriptional regulatory regions of vascular endothelial growth factor receptor 2 (VEGFR2) in amyotrophic lateral sclerosis.
BMC medical genetics - 24 Apr 2007
Brockington Alice, Wokke Beatrijs, Nixon Hannah, Hartley Judith, Shaw Pamela J
Abstract excerpt
BACKGROUND: Vascular endothelial growth factor (VEGF) has neurotrophic activity which is mediated by its main agonist receptor, VEGFR2. Dysregulation of VEGF causes motor neurone degeneration in a mouse model of amyotrophic lateral sclerosis (ALS), and expression of VEGFR2 is reduced in motor neurones and spinal cord of patients with ALS. METHODS: We have screened the promoter region and 4 exonic regions of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
